உபசரிப்பு முதுமறதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உபசரிப்பு முதுமறதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உபசரிப்பு முதுமறதி Today - Breaking & Trending Today

DGAP-News: Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer's Disease in Greater China Seite 1


DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Agreement
Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer s Disease in Greater
China
29.06.2021 / 01:03
The issuer is solely responsible for the content of this announcement.
Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer s Disease in Greater
China
Halle (Saale)/Munich, Germany and Nanjing, China, June 29, 2021 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon) a clinical-stage biotechnology company focused
on developing innovative small molecule-based medicines and Simcere Pharmaceutical Group Ltd (HKEX: 2096) (Simcere) today announced that they have entered into a strategic regional li ....

Simcere Announce Strategic Regional Licensing Partnership To , Simcere Pharmaceutical Group Ltd , Vivoryon Therapeutics , Treat Alzheimer , Greater China , Euronext Amsterdam , Agreement Vivoryon Therapeutics , உபசரிப்பு முதுமறதி , அதிகமானது சீனா ,